123 related articles for article (PubMed ID: 38642360)
1. Immunohistochemical study of CD74 biomarker in normal and malignant breast tissues.
Hassan HN; Al-Hussein RKA; Al-Naqeeb AA
Pol Merkur Lekarski; 2024; 52(2):233-239. PubMed ID: 38642360
[TBL] [Abstract][Full Text] [Related]
2. CD74 interacts with CD44 and enhances tumorigenesis and metastasis via RHOA-mediated cofilin phosphorylation in human breast cancer cells.
Liu Z; Chu S; Yao S; Li Y; Fan S; Sun X; Su L; Liu X
Oncotarget; 2016 Oct; 7(42):68303-68313. PubMed ID: 27626171
[TBL] [Abstract][Full Text] [Related]
3. CD74: a potential novel target for triple-negative breast cancer.
Tian B; Zhang Y; Li N; Liu X; Dong J
Tumour Biol; 2012 Dec; 33(6):2273-7. PubMed ID: 22935920
[TBL] [Abstract][Full Text] [Related]
4. Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer.
Richard V; Kindt N; Decaestecker C; Gabius HJ; Laurent G; Noël JC; Saussez S
Oncol Rep; 2014 Aug; 32(2):523-9. PubMed ID: 24939415
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD74 in invasive breast carcinoma: its relation to Nottingham Prognostic Index, hormone receptors, and HER2 immunoprofile.
Hasby EA; Khalifa RA
Tumori; 2017 Mar; 103(2):193-203. PubMed ID: 27834468
[TBL] [Abstract][Full Text] [Related]
6. Stat1 and CD74 overexpression is co-dependent and linked to increased invasion and lymph node metastasis in triple-negative breast cancer.
Greenwood C; Metodieva G; Al-Janabi K; Lausen B; Alldridge L; Leng L; Bucala R; Fernandez N; Metodiev MV
J Proteomics; 2012 Jun; 75(10):3031-40. PubMed ID: 22178447
[TBL] [Abstract][Full Text] [Related]
7. [Expression of cluster of differentiation 74 in prostate cancer and its clinical significance].
Tian ZB; Qi WC; Jin RS
Zhonghua Nan Ke Xue; 2020 Feb; 26(2):123-127. PubMed ID: 33346414
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of CD74 in gastrointestinal cancers and benign tissues.
Gold DV; Stein R; Burton J; Goldenberg DM
Int J Clin Exp Pathol; 2010 Nov; 4(1):1-12. PubMed ID: 21228923
[TBL] [Abstract][Full Text] [Related]
9. CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis.
Loreth D; Schuette M; Zinke J; Mohme M; Piffko A; Schneegans S; Stadler J; Janning M; Loges S; Joosse SA; Lamszus K; Westphal M; Müller V; Glatzel M; Matschke J; Gebhardt C; Schneider SW; Belczacka I; Volkmer B; Greinert R; Yaspo ML; Harter PN; Pantel K; Wikman H
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209696
[TBL] [Abstract][Full Text] [Related]
10. CD74 expression is increased in high-grade, invasive urothelial carcinoma of the bladder.
Choi JW; Kim Y; Lee JH; Kim YS
Int J Urol; 2013 Feb; 20(2):251-5. PubMed ID: 22905972
[TBL] [Abstract][Full Text] [Related]
11. CD74 and intratumoral immune response in breast cancer.
Wang ZQ; Milne K; Webb JR; Watson PH
Oncotarget; 2017 Feb; 8(8):12664-12674. PubMed ID: 27058619
[TBL] [Abstract][Full Text] [Related]
12. CD74 is a novel prognostic factor for patients with pancreatic cancer receiving multimodal therapy.
Nagata S; Jin YF; Yoshizato K; Tomoeda M; Song M; Iizuka N; Kitamura M; Takahashi H; Eguchi H; Ohigashi H; Ishikawa O; Tomita Y
Ann Surg Oncol; 2009 Sep; 16(9):2531-8. PubMed ID: 19499276
[TBL] [Abstract][Full Text] [Related]
13. CD74 expression and its therapeutic potential in thyroid carcinoma.
Cheng SP; Liu CL; Chen MJ; Chien MN; Leung CH; Lin CH; Hsu YC; Lee JJ
Endocr Relat Cancer; 2015 Apr; 22(2):179-90. PubMed ID: 25600560
[TBL] [Abstract][Full Text] [Related]
14. CD74-dependent deregulation of the tumor suppressor scribble in human epithelial and breast cancer cells.
Metodieva G; Nogueira-de-Souza NC; Greenwood C; Al-Janabi K; Leng L; Bucala R; Metodiev MV
Neoplasia; 2013 Jun; 15(6):660-8. PubMed ID: 23730214
[TBL] [Abstract][Full Text] [Related]
15. CD74 is expressed by multiple myeloma and is a promising target for therapy.
Burton JD; Ely S; Reddy PK; Stein R; Gold DV; Cardillo TM; Goldenberg DM
Clin Cancer Res; 2004 Oct; 10(19):6606-11. PubMed ID: 15475450
[TBL] [Abstract][Full Text] [Related]
16. Up-Regulation of CD74 Expression in Parietal Epithelial Cells in a Mouse Model of Focal Segmental Glomerulosclerosis.
Yamazaki T; Sasaki S; Okamoto T; Sato Y; Hayashi A; Ariga T
Nephron; 2016; 134(4):238-252. PubMed ID: 27463800
[TBL] [Abstract][Full Text] [Related]
17. Involvement of CD74 in head and neck squamous cell carcinomas.
Kindt N; Lechien JR; Nonclercq D; Laurent G; Saussez S
J Cancer Res Clin Oncol; 2014 Jun; 140(6):937-47. PubMed ID: 24663824
[TBL] [Abstract][Full Text] [Related]
18. Expression of MHC class II-associated invariant chain (Ii;CD74) in thymic epithelial neoplasms.
Datta MW; Shahsafaei A; Nadler LM; Freeman GJ; Dorfman DM
Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):210-5. PubMed ID: 10981873
[TBL] [Abstract][Full Text] [Related]
19. Differential CD74 (major histocompatibility complex Class II invariant chain) expression in mouse and human intestinal adenomas.
Cuthbert RJ; Wilson JM; Scott N; Coletta PL; Hull MA
Eur J Cancer; 2009 Jun; 45(9):1654-63. PubMed ID: 19269807
[TBL] [Abstract][Full Text] [Related]
20. Expression of invariant chain (CD 74) and major histocompatibility complex (MHC) class II antigens in the human fetus.
Badve S; Deshpande C; Hua Z; Lögdberg L
J Histochem Cytochem; 2002 Apr; 50(4):473-82. PubMed ID: 11897800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
